Skip to content

Clinical trials

Completed Carcinoma, Non-Small-Cell Lung trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Completed Country / region: India Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20043
20051
20062
20074
200811
20092
20105
20112
20122
20132
20153
20173
20186
20194
20203
20212
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed61

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca11
Eli Lilly and Company9
Boehringer Ingelheim5
Genzyme, a Sanofi Company4
Hoffmann-La Roche4
Novartis Pharmaceuticals3
Peregrine Pharmaceuticals3
Pfizer3
Bayer2
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung61
Lung Neoplasms15
Carcinoma3
Melanoma2
Small Cell Lung Carcinoma2
Adenocarcinoma of Lung1
Biliary Tract Neoplasms1
Breast Neoplasms1
Bronchial Neoplasms1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.